Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 14207 publications
Yes Tyrosine Kinase Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Yes Tyrosine Kinase Inhibitors pipeline on the basis of target, MOA, route of administration, technology ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Xanthine Oxidase Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Xanthine Oxidase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Xanthine ...

Jul, 2014
Wnt Signaling Pathway Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... the understanding for all the pipeline drugs that fall under Wnt Signaling Pathway Inhibitors. This report provides information on the ... , development partner and chemical information Coverage of the Wnt Signaling Pathway Inhibitors pipeline on the basis of target, MOA, route of administration, technology ...

Jul, 2014
Wee1 Tyrosine Kinase inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Wee1 Tyrosine Kinase inhibitors pipeline on the basis of target, MOA, route of administration, technology ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Voltage-Gated Sodium Channel Blockers -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Voltage-Gated Sodium Channel Blockers pipeline on the basis of target, MOA, route of administration, ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Voltage-Dependent T-Type Calcium Channel Blockers -Pipeline Insights, 2014 US$ 1,250.00

... T-Type Calcium Channel Blockers Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision ... . Devise corrective measures for pipeline projects by understanding Voltage-Dependent T-Type Calcium Channel Blockers pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Voltage-Dependent N-Type Calcium Channel Blockers -Pipeline Insights, 2014 US$ 1,250.00

... N-Type Calcium Channel Blockers Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision ... . Devise corrective measures for pipeline projects by understanding Voltage-Dependent N-Type Calcium Channel Blockers pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Voltage-Dependent Calcium Channel Blockers -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Voltage-Dependent Calcium Channel Blockers pipeline on the basis of target, MOA, route of administration, ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers -Pipeline Insights, 2014 US$ 1,250.00

... Channel Alpha-2/Delta Blockers and also provide company profiling The report also gives the information of dormant and discontinued pipeline ... corrective measures for pipeline projects by understanding Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development ...

Jul, 2014
Viral RNA Polymerase Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Viral RNA Polymerase Inhibitors pipeline on the basis of target, MOA, route of administration, technology ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Viral Protease Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... SUMMARY DelveInsight’s,“Viral Protease Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Viral DNA Polymerase Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Viral DNA Polymerase Inhibitors pipeline on the basis of target, MOA, route of administration, technology ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2014 US$ 1,250.00

... for all the pipeline drugs that fall under VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor. This report provides information ... report provides a snapshot of the global therapeutic landscape of VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor The report provides pipeline ...

Jul, 2014
Vasopressin V2 Receptor (V2R) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Vasopressin V2 Receptor (V2R) Antagonists pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development activities. ...

Jul, 2014
Vasopressin V2 Receptor (V2R) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... use it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Vasopressin V2 Receptor (V2R) Agonists pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development activities. ...

Jul, 2014
Vasopressin V1a Receptor (V1aR) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Vasopressin V1a Receptor (V1aR) Antagonists pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development activities. ...

Jul, 2014
Vasopressin Receptor Antagonists -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Vasopressin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Vasopressin ...

Jul, 2014
Vasopressin Receptor Agonists -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Vasopressin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Vasopressin Receptor ...

Jul, 2014
Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights, 2014 US$ 1,250.00

... drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Vascular Endothelial Growth Factor A (VEGF-A) Activator pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Vascular Adhesion Protein 1 (VAP-1) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Vascular Adhesion Protein 1 (VAP-1) Inhibitors pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development activities ...

Jul, 2014
UMP-CMP Kinase (UMP-CMPK) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the UMP-CMP Kinase (UMP-CMPK) Inhibitors pipeline on the basis of target, MOA, route of administration, ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
Ubiquitin Specific Proteases (USP) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Ubiquitin Specific Proteases (USP) Inhibitors pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development activities. ...

Jul, 2014
Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... ). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Tumor Necrosis Factor Receptor ... . Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor (TNFR) Antagonists pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... key players involved in the therapeutics development for Tumor Necrosis Factor Alpha (TNF-a) Agonists and also provide company profiling The ... . Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Alpha (TNF-a) Agonists pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... ). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Tumor Necrosis Factor (TNF) ... . Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor (TNF) Inhibitors pipeline depth and focus of Indication therapeutics Developing ...

Jul, 2014
Tumor Necrosis Factor (TNF) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Tumor ... . Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor (TNF) Agonists pipeline depth and focus of Indication therapeutics Developing ...

Jul, 2014
Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... section which includes product description, MOA, licensors & collaborators, development partner and chemical information Coverage of the Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type ...

Jul, 2014
Trypsin Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Trypsin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... for all the pipeline drugs that fall under TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists ... . Devise corrective measures for pipeline projects by understanding TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists ...

Jul, 2014
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... molecule type Reasons to buy Complete MOA intelligence and complete understanding over therapeutics development for Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonists Identify the relationship between the drugs and use it for target finding ...

Jul, 2014
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... molecule type Reasons to buy Complete MOA intelligence and complete understanding over therapeutics development for Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonists Identify the relationship between the drugs and use it for target finding, ...

Jul, 2014
Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... of development and molecule type Reasons to buy Complete MOA intelligence and complete understanding over therapeutics development for Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonists Identify the relationship between the drugs and use it for target finding, drug ...

Jul, 2014
Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... of development and molecule type Reasons to buy Complete MOA intelligence and complete understanding over therapeutics development for Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonists Identify the relationship between the drugs and use it for target finding, drug ...

Jul, 2014
Transglutaminase 2 Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Transglutaminase 2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Transglutaminase 2 ...

Jul, 2014
Transforming Growth Factor Beta (TGFb) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... Beta (TGFb) Inhibitors Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Transforming Growth Factor Beta (TGFb) Inhibitors pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Transforming Growth Factor Alpha (TGFa) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... Factor Alpha (TGFa) Inhibitors Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision ... . Devise corrective measures for pipeline projects by understanding Transforming Growth Factor Alpha (TGFa) Inhibitors pipeline depth and focus of Indication therapeutics ...

Jul, 2014
Transcription Factor Activator Protein-1 (AP-1) Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

... it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding Transcription Factor Activator Protein-1 (AP-1) Inhibitors pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug development ...

Jul, 2014
TRAIL Receptor Agonists -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“TRAIL Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Jul, 2014
TRAIL Receptor 2 (TRAIL-R2 or Death Receptor 5 or DR5) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... use it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding TRAIL Receptor 2 (TRAIL-R2 or Death Receptor 5 or DR5) Agonists pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug ...

Jul, 2014
TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists -Pipeline Insights, 2014 US$ 1,250.00

... use it for target finding, drug repurposing, and precision medicine. Devise corrective measures for pipeline projects by understanding TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists pipeline depth and focus of Indication therapeutics Developing strategic initiatives to support your drug ...

Jul, 2014
Topoisomerase Inhibitors -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Topoisomerase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Topoisomerase Inhibitors. ...

Jul, 2014
Toll-Like Receptor Antagonists -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Toll-Like Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ... been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White ...

Jul, 2014
Toll-Like Receptor Agonists -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“Toll-Like Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ... has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White ...

Jul, 2014
Toll-Like Receptor 9 (TLR-9) Antagonists -Pipeline Insights, 2014 US$ 1,250.00

... ). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Toll-Like Receptor 9 (TLR ... . Devise corrective measures for pipeline projects by understanding Toll-Like Receptor 9 (TLR-9) Antagonists pipeline depth and focus of Indication therapeutics Developing ...

Jul, 2014
1 2 3 4 5 >
Skip to top